Navigation Links
Flu breakthrough: New drug developed to combat flu pandemic
Date:2/22/2013

The new drug has been proven to be effective in preventing the spread of different strains of influenza in laboratory models including resistant strains of the virus.

The breakthrough is the result of a global collaboration between scientists from CSIRO, the University of British Columbia and the University of Bath.

In order to infect cells, flu viruses bind onto sugars on the cell surface. To be able to spread they need to remove these sugars. The new drug works by preventing the virus from removing sugars and blocking the virus from infecting more cells. It is hoped the drug will also be effective against future strains of the virus.

According to the World Health Organisation, influenza kills approximately 500,000 people each year, with up to 2500 of those deaths occurring in Australia[1]. Costs to the Australian health care system are estimated to be more than A$85M, with more than 1.5 million work days lost annually

CSIRO scientist Dr Jenny McKimm-Breschkin, a researcher in the team that developed the first flu drug Relenza, said that understanding exactly how flu viruses become resistant to drugs has helped them to design a better flu drug.

"CSIRO researchers have shown that flu viruses continually mutate and some have become resistant to available treatments," Dr Jenny McKimm-Breschkin said.

"The new drug is effective against these resistant strains. As the site where the drug binds is found in all flu strains, the new drug is expected to be effective even against future flu strains.

"With millions of poultry currently infected with 'bird flu' globally, there are still concerns about its adaptation and potential to spread among humans, causing the next pandemic," she added.

Professor Steve Withers, University of British Columbia, has led the research team for the past seven years and said that although further studies are required to determine efficacy against a broader range of flu stra
'/>"/>

Contact: Angela Beggs
angela.beggs@csiro.au
61-395-452-977
CSIRO Australia
Source:Eurekalert

Page: 1 2

Related biology news :

1. Breakthrough: How salt stops plant growth
2. Research breakthrough: High brain integration underlies winning performances
3. University-developed omega-3-rich ground beef available soon
4. How the protein transport machinery in the chloroplasts of higher plants developed
5. High Brightness Tetrapod Quantum Dots Developed
6. Test developed to detect early-stage diseases with naked eye
7. New cranial neural crest cell line developed
8. Humanized mice developed at OHSU enable malaria research breakthrough at Seattle BioMed
9. New long-term antimicrobial catheter developed
10. Electronic nose prototype developed
11. Composite nanofibers developed by Penn scientists next chapter in orthopaedic biomaterials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... market, reminds investors and media that  Mr. David Tunnell ... SECURE CONNEXIONS AMERICA 2015, held in Washington DC ... conference is organized into a series of nine session tracks. ... Fraud: Where is the Trust in Cyberspace? and will ...
(Date:4/20/2015)... April 20, 2015 Huntington Memorial Hospital is ... implant a new miniaturized, wireless monitoring sensor to manage ... first and only FDA-approved heart failure monitoring device that ... used by physicians to manage heart failure. ... implanted in the pulmonary artery (PA) during a non-surgical ...
(Date:4/13/2015)... YORK , April 13, 2015 ... by TechSci Research, "Global Biometrics Market Forecast & Opportunities, ... register a CAGR of around 14% till 2020. ... governments for large scale implementation and review of ... and launch of new products with greater efficiency, ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... visiting researcher from Sweden in the Indiana University College of ... in culturing, characterizing and formally naming a new class of ... from environmental samples. ,Structures on Roots ... Soil Clone Group 1 (SCG1), has now been found in ...
... New research led by scientists from Imperial College London explains ... phase, of symptoms several hours after exposure to allergens. The ... to better treatments for the disease. An estimated 300 ... Symptoms are commonly triggered by allergens in the environment, such ...
... A thriving undersea wildlife park tucked away near the southern ... world,s most robust marine reserve in the world, according to ... Oceanography at UC San Diego. Results of a ... the Public Library of Science (PLoS) ONE journal, ...
Cached Biology News:Visiting researcher at IU leads international team in formal identification of new fungi class 2Visiting researcher at IU leads international team in formal identification of new fungi class 3Study sheds light on late phase of asthma attacks 2Hidden Baja undersea park is the world's most robust marine reserve 2Hidden Baja undersea park is the world's most robust marine reserve 3
(Date:5/28/2015)... 2015 Global futurist and keynote ... ask his audiences if they are ready for ... solar cells, fuel cells, rapid health care diagnostic ... storage technology, driverless cars, artificial intelligence masquerading as ... online education. , While the majority of ...
(Date:5/27/2015)... -- The Companion Diagnostics Deals and Alliances of 2014 ... the partnering deals and agreements entered into by ... Using these reports, dealmakers will effectively and ... the past year. The report series allows you ... announced worldwide.The initial chapters of this report provide ...
(Date:5/27/2015)... Expanding in a big way into the Japanese ... recently inked a deal with Arthur Mokuda, president ... the largest endodontic distributor in Japan. The move represents ... Biomed, which manufactures Grey MTA Plus® and the newly ... have won renown from dentists around the world. , ...
(Date:5/27/2015)... , May 27, 2015  CytomX, a ... of cancer, today announced the appointments of ... Cynthia Ladd as senior vice president ... was chief financial officer of Onyx Pharmaceuticals, an ... independent consultant and legal counsel to several leading ...
Breaking Biology Technology:Futurist Jack Uldrich to Deliver 4 Keynote Addresses in June 2Companion Diagnostics Deals and Alliances of 2014 2Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 2Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 3CytomX Expands Executive Leadership Team 2CytomX Expands Executive Leadership Team 3
... Technologies,Corporation,s (OTC Bulletin Board: CNVT) holding BIOREM announced the,receipt ... China for a,Biofiltair odor control system. This order for ... (Cdn) and is the third order,received from China over ... our technology was accepted on these projects,",said Peter Bruijns, ...
... RDEA ) today announced that its President and ... the "In Search of the,Next HIV Treatment" panel discussion ... December 12, 2007 at 1:30 p.m. (ET) at,the Westin ... audio webcast of the,presentation and panel discussion will be ...
... North America with this Elevated Partner ... ... System,Integrator, today announced it has achieved Oracle Certified Advantage,Partner status in the ... level in the Oracle PartnerNetwork -- BIAS had,to demonstrate superior product knowledge ...
Cached Biology Technology:CVF Technologies Corporation's Holding - BIOREM Announces 3rd Order from China 2Ardea Biosciences to Participate in RBC Capital Markets 2007 Healthcare Conference 2Ardea Biosciences to Participate in RBC Capital Markets 2007 Healthcare Conference 3BIAS Achieves Certified Advantage Partner Level in Oracle PartnerNetwork 2BIAS Achieves Certified Advantage Partner Level in Oracle PartnerNetwork 3
... GeneMarker software has been designed and created ... a biologist friendly genotyping analysis tool. We ... research groups into the software. Their main ... flexibility and low acquisition cost. GeneMarker ...
...
... Free Epitope Design consultation. ... up to 17 amino acids). Conjugation ... to researcher. Immunization of 2 New ... protocol including 5 immunizations and 4 production ...
Biotin or fluorescent labels can be attached and the stoichiometry of protein labeling determined....
Biology Products: